Amaan Rahman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Amaan Rahman has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Amber Dianne Shaffer
University of Pittsburgh School of Medicine
1 shared publication Brandon Smith
University of Pittsburgh Medical Center, Department of Otolaryngology, Head and Neck Surgery, Pittsburgh, PA, USA
1 shared publicationElonay Yehualashet
Division of Vascular Surgery, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
1 shared publication- Hind Anan
Division of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA
1 shared publication - Jacob Weineberg
Geisinger Commonwealth School of Medicine, Scranton, Pennsylvania
1 shared publication - Joshua D. Smith
University of Pittsburgh Medical Center, Department of Otolaryngology, Head and Neck Surgery, Pittsburgh, PA, USA
1 shared publication
Latest Publications
- 6 July 2026
- Published by Wiley in The Laryngoscope
- Vol. 136 (11) , 5082-5087
Practice Patterns for the Management of Pediatric oSDB : What Is the Current National Landscape?
Objective: As understanding of pediatric obstructive sleep‐disordered breathing (oSDB) evolves, a need remains for clinical consensus within pediatric otolaryngology. We aimed to characterize current national practice patterns in the evaluation and management of pediatric oSDB, including obstructive sleep apnea (OSA), among pediatric otolaryngologists. Methods: We performed a cross‐sectional study of the current 450 ASPO members via an anonymous, confidential, secure, and voluntary online survey. The survey queried practicing pediatric otolaryngologists regarding tonsillectomy techniques, drug‐induced sleep endoscopy (DISE), and multidisciplinary care in the management of pediatric oSDB. Results: Of the 450 current ASPO members invited to participate, 212 (47%) completed the survey. There was wide variability with respect to extracapsular versus intracapsular tonsillectomy techniques for oSDB and OSA indications, with 70% performing intracapsular dissection as part of their practice. A total of 169 respondents (81%) performed DISE, with almost all respondents (99.1%) using a standardized grading scale. Practice patterns did emerge, with more junior surgeons (in practice < 10 years) and those in academic practice being more likely to perform intracapsular tonsillectomy and DISE in clinical practice compared to more senior counterparts and those working in a nonacademic setting ( p < 0.05 for each metric). Multi‐disciplinary care of complex or persistent OSA was more common in academic versus nonacademic settings (64% vs. 26%) ( p < 0.001). Conclusion: Notable variability in pediatric oSDB management across the current national landscape highlights the need to standardize aspects of care, including the role of intracapsular tonsillectomy, pediatric DISE protocols, and multidisciplinary care. Level of Evidence: 5
- 6 July 2026
- Published by Wiley in The Laryngoscope
- Vol. 136 (11) , 5082-5087
Practice Patterns for the Management of Pediatric oSDB : What Is the Current National Landscape?
Objective: As understanding of pediatric obstructive sleep‐disordered breathing (oSDB) evolves, a need remains for clinical consensus within pediatric otolaryngology. We aimed to characterize current national practice patterns in the evaluation and management of pediatric oSDB, including obstructive sleep apnea (OSA), among pediatric otolaryngologists. Methods: We performed a cross‐sectional study of the current 450 ASPO members via an anonymous, confidential, secure, and voluntary online survey. The survey queried practicing pediatric otolaryngologists regarding tonsillectomy techniques, drug‐induced sleep endoscopy (DISE), and multidisciplinary care in the management of pediatric oSDB. Results: Of the 450 current ASPO members invited to participate, 212 (47%) completed the survey. There was wide variability with respect to extracapsular versus intracapsular tonsillectomy techniques for oSDB and OSA indications, with 70% performing intracapsular dissection as part of their practice. A total of 169 respondents (81%) performed DISE, with almost all respondents (99.1%) using a standardized grading scale. Practice patterns did emerge, with more junior surgeons (in practice < 10 years) and those in academic practice being more likely to perform intracapsular tonsillectomy and DISE in clinical practice compared to more senior counterparts and those working in a nonacademic setting ( p < 0.05 for each metric). Multi‐disciplinary care of complex or persistent OSA was more common in academic versus nonacademic settings (64% vs. 26%) ( p < 0.001). Conclusion: Notable variability in pediatric oSDB management across the current national landscape highlights the need to standardize aspects of care, including the role of intracapsular tonsillectomy, pediatric DISE protocols, and multidisciplinary care. Level of Evidence: 5
- 2 July 2026
- Published by Elsevier in Oral Oncology
- Vol. 180, 108066
3D Volumetric-Based resection modeling to optimize reconstructive outcomes for ablative oral cavity defects
- 2 July 2026
- Published by Elsevier in Oral Oncology
- Vol. 180, 108066
3D Volumetric-Based resection modeling to optimize reconstructive outcomes for ablative oral cavity defects
- Open Access
- 5 May 2026
- Published by Wolters Kluwer Health in Kidney360
- Vol. 7 (8) , 1807-1814
Contemporary Comparison between the Hemodialysis Reliable Outflow Device and Femoral Arteriovenous Graft
Key Points: Previously, femoral arteriovenous grafts were the standard approach for patients with upper extremity central venous occlusion. In our study, hemodialysis reliable outflow offered a higher likelihood of obtaining functional patency and fewer complications compared with femoral arteriovenous graft. These findings highlight that hemodialysis reliable outflow graft is a viable option for patients who have exhausted upper extremity arteriovenous access. Background: Hemodialysis reliable outflow (HeRO) graft and femoral arteriovenous graft (fAVG) are alternative options for patients who have exhausted upper extremity arteriovenous access because of central venous occlusion. This study aims to provide a contemporary comparison between HeRO and fAVG. Methods: Retrospective chart review of consecutive fAVG and HeRO placed between 2016 and 2023 at a multihospital health care system was conducted. Patients were identified using the local Vascular Quality Initiative database and supplemented by charts review. Baseline characteristics, operative details, and follow-up data were obtained. Data were analyzed using standard statistical tests, Kaplan–Meier survival analysis, and multivariate Cox proportional hazards. Results: Data for 114 access were collected (68 HeRO, 46 fAVG) from 105 unique patients. Patients receiving HeRO graftswere older (66.1 versus 57.7 years), had higher body mass index (31.8 versus 27.9 kg/m 2 ), and were more likely to have a history of atrial fibrillation (56% versus 20%) and fewer previous arteriovenous accesses (mean 1.4 versus 2.4). The ability to use the graft for hemodialysis was higher in the HeRO group (94% versus 83%; P = 0.049). At 36 months, the primary patency rate was 5% for the HeRO graft and 17% for the fAVG ( P = 0.45), while the secondary patency rates were 30% and 54% ( P = 0.25), respectively. Thrombosis was the predominant cause of HeRO graft abandonment (78%), whereas infection was most common for fAVGs (44%). On Kaplan‑Meier analysis, mortality was similar for HeRO graft and fAVG ( P = 0.22). Six (9%) patients from the HeRO group and ten (22%) from the fAVG group underwent graft removal because of infection ( P = 0.05). The rate of steal did not differ between both groups (HeRO 6% versus fAVG 11%; P = 0.33); however, among patients receiving fAVG, two required access ligation and two underwent limb amputation (HeRO, 0% versus fAVG, 9%; P = 0.01). Conclusions: HeRO graft is a reasonable alternative for patients who have exhausted upper extremity arteriovenous access, offering a higher likelihood of obtaining functional patency and fewer complications compared with fAVG.
- 5 May 2026
- Published by Wolters Kluwer Health in Kidney360
- Vol. 7 (8) , 1807-1814
Open AccessContemporary Comparison between the Hemodialysis Reliable Outflow Device and Femoral Arteriovenous Graft
Key Points: Previously, femoral arteriovenous grafts were the standard approach for patients with upper extremity central venous occlusion. In our study, hemodialysis reliable outflow offered a higher likelihood of obtaining functional patency and fewer complications compared with femoral arteriovenous graft. These findings highlight that hemodialysis reliable outflow graft is a viable option for patients who have exhausted upper extremity arteriovenous access. Background: Hemodialysis reliable outflow (HeRO) graft and femoral arteriovenous graft (fAVG) are alternative options for patients who have exhausted upper extremity arteriovenous access because of central venous occlusion. This study aims to provide a contemporary comparison between HeRO and fAVG. Methods: Retrospective chart review of consecutive fAVG and HeRO placed between 2016 and 2023 at a multihospital health care system was conducted. Patients were identified using the local Vascular Quality Initiative database and supplemented by charts review. Baseline characteristics, operative details, and follow-up data were obtained. Data were analyzed using standard statistical tests, Kaplan–Meier survival analysis, and multivariate Cox proportional hazards. Results: Data for 114 access were collected (68 HeRO, 46 fAVG) from 105 unique patients. Patients receiving HeRO graftswere older (66.1 versus 57.7 years), had higher body mass index (31.8 versus 27.9 kg/m 2 ), and were more likely to have a history of atrial fibrillation (56% versus 20%) and fewer previous arteriovenous accesses (mean 1.4 versus 2.4). The ability to use the graft for hemodialysis was higher in the HeRO group (94% versus 83%; P = 0.049). At 36 months, the primary patency rate was 5% for the HeRO graft and 17% for the fAVG ( P = 0.45), while the secondary patency rates were 30% and 54% ( P = 0.25), respectively. Thrombosis was the predominant cause of HeRO graft abandonment (78%), whereas infection was most common for fAVGs (44%). On Kaplan‑Meier analysis, mortality was similar for HeRO graft and fAVG ( P = 0.22). Six (9%) patients from the HeRO group and ten (22%) from the fAVG group underwent graft removal because of infection ( P = 0.05). The rate of steal did not differ between both groups (HeRO 6% versus fAVG 11%; P = 0.33); however, among patients receiving fAVG, two required access ligation and two underwent limb amputation (HeRO, 0% versus fAVG, 9%; P = 0.01). Conclusions: HeRO graft is a reasonable alternative for patients who have exhausted upper extremity arteriovenous access, offering a higher likelihood of obtaining functional patency and fewer complications compared with fAVG.